시장보고서
상품코드
1747305

동물용 마취제 시장 : 마취제 클래스별, 동물 유형별, 투여 경로별, 용도별, 유통 채널별, 최종사용자별, 지역별

Veterinary Anesthesia Drugs Market, By Anesthetic Drug Class, By Animal Type, By Route of Administration, By Application, By Distribution Channel, By End User, By Geography

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

동물용 마취제 세계 시장은 2025년에는 5억 1,120만 달러, 2032년까지는 7억 8,920만 달러에 이를 것으로 예측되며, 2025-2032년 CAGR 6.4%를 보일 것으로 예측됩니다.

보고서 범위 보고서 상세
기준 연도 2024년 2025년 시장 규모 5억 1,120만 달러
실적 데이터 2020-2024년/td> 예측 기간 2025-2032년
예측 기간(2025-2032년) CAGR 6.40% 2032년 금액 예측 7억 8,920만 달러

세계 동물용 마취제 시장은 고급 수의학적 치료에 대한 수요 증가와 반려동물의 만성질환 유병률 증가에 힘입어 최근 몇 년 동안 괄목할 만한 성장세를 보이고 있습니다. 동물용 마취제는 다양한 외과 수술에서 중요한 역할을 하며, 의료 개입 중 동물의 안전과 편안함을 보장합니다. 이 약품들은 마취 유도 및 유지, 진통 및 근육 이완을 통해 수의사가 복잡한 수술 및 진단 절차를 수행할 수 있도록 하는 데 사용됩니다. 이 시장에는 주사 마취제, 흡입 마취제, 국소 마취제 등 다양한 마취제가 포함되며, 각기 다른 특성과 용도를 가지고 있습니다. 전 세계적으로 반려동물 사육률이 지속적으로 증가하고 반려동물 보호자들이 반려동물을 위한 고급 의료 서비스에 대한 투자를 원함에 따라 동물용 마취제에 대한 수요는 향후 몇 년 동안 더욱 확대될 것으로 예측됩니다.

시장 역학

세계 동물용 마취제 시장은 성장을 가속하고 과제와 기회를 제공하는 몇 가지 중요한 요인의 영향을 받고 있습니다. 주요 촉진요인 중 하나는 반려동물 수 증가와 반려동물을 위한 고품질 의료 서비스에 대한 보호자들의 투자 의지에 힘입어 고급 수의학적 치료에 대한 수요가 증가하고 있다는 점입니다. 또한, 반려동물의 암, 심혈관 질환, 정형외과 질환 등 만성 질환의 유병률이 증가함에 따라 수술 건수가 증가하고 있으며, 이는 동물용 마취제에 대한 수요를 더욱 증가시키고 있습니다. 그러나 시장에는 마취제 및 마취기구의 높은 비용과 같은 억제요인도 있어 비용에 민감한 지역에서는 도입이 제한적일 수 있습니다. 또한, 동물용 마취제에 대한 표준화된 프로토콜의 부재와 특정 마취제와 관련된 잠재적인 부작용이 시장 성장에 걸림돌이 될 수 있습니다. 이러한 시장 성장 억제요인에도 불구하고, 시장은 제조업체와 공급업체에게 큰 기회를 제공합니다. 혁신적이고 안전한 마취제 개발과 최소침습 수술에 대한 관심이 높아지면서 시장 확대의 원동력이 될 것으로 예측됩니다. 또한, 신흥국의 동물용 마취제에 대한 수요 증가와 동물 병원 및 클리닉 네트워크의 확대는 시장 기업에게 유리한 성장 전망을 제공합니다.

본 조사의 주요 특징

  • 세계의 동물용 마취제 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR%)을 조사하여 전해드립니다.
  • 다양한 부문에 걸친 잠재적 수익 창출 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
  • 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 동물용 마취제 시장의 주요 기업을 프로파일링합니다.
  • 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
  • 동물용 마취제 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자들은 세계 동물용 마취제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 전망

  • 보고서 설명
    • 시장 정의와 범위
  • 주요 요약

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 영향 분석
  • 주요 발전
  • 규제 시나리오
  • 제품 발매 및 승인
  • PEST 분석
  • PORTER 분석
  • 인수합병(M&A) 시나리오
  • 업계 동향

제4장 세계의 동물용 마취제 시장, 마취제 클래스별, 2020년-2032년

  • 전신 마취제
  • 바르비투르산염
  • 해리제(예 : 케타민)
  • 흡입제(예 : 이소플루란, 세보풀루란)
  • 국소 마취제
  • 리도카인
  • 부피바카인
  • 보조제
  • 진정제(예 : 덱스메데토미딘, 메데토미딘)
  • 진통제(예 : 오피오이드, NSAID)
  • 신경근 차단제

제5장 세계의 동물용 마취제 시장, 동물 유형별, 2020년-2032년

  • 반려동물
  • 가축

제6장 세계의 동물용 마취제 시장, 투여 경로별, 2020년-2032년

  • 정맥내
  • 근육내
  • 흡입
  • 국소
  • 기타(경구 수술전 진정)

제7장 세계의 동물용 마취제 시장, 용도별, 2020년-2032년

  • 외과 수술
  • 진단 절차
  • 통증 관리

제8장 세계의 동물용 마취제 시장, 유통 채널별, 2020년-2032년

  • 동물용 의약품점
  • 온라인 약국
  • 소매 약국

제9장 세계의 동물용 마취제 시장, 최종사용자별, 2020년-2032년

  • 병원 및 진료소
  • 학술기관 및 연구기관
  • 이동식 수의 유닛
  • 기타

제10장 세계의 동물용 마취제 시장, 지역별, 2020년-2032년, 금액

  • 북미
      • 미국
      • 캐나다
  • 라틴아메리카
      • 브라질
      • 아르헨티나
      • 멕시코
      • 기타 라틴아메리카
  • 유럽
      • 독일
      • 영국
      • 스페인
      • 프랑스
      • 이탈리아
      • 러시아
      • 기타 유럽
  • 아시아태평양
      • 중국
      • 인도
      • 일본
      • 호주
      • 한국
      • ASEAN
      • 기타 아시아태평양
  • 중동
      • GCC 국가
      • 이스라엘
      • 기타 중동
  • 아프리카
      • 남아프리카
      • 북아프리카
      • 중앙아프리카

제11장 경쟁 구도

  • Zoetis
  • Merck Animal Health
  • Elanco
  • Bayer Animal Health
  • Vetoquinol
  • Dechra Pharmaceuticals
  • Cegelec
  • Jorgensen Laboratories
  • Abaxis
  • VetMedin
  • Henry Schein Animal Health
  • MWI Animal Health
  • IDEXX Laboratories
  • Neogen Corporation
  • Virbac

제12장 애널리스트의 제안

  • Wheel of Fortune
  • 애널리스트의 견해
  • Coherent Opportunity Map

제13장 참고 문헌과 조사 방법

  • 참고 문헌
  • 조사 방법
  • 출판사에 대해
LSH 25.06.24

Global Veterinary Anesthesia Drugs Market is estimated to be valued at USD 511.2 Mn in 2025 and is expected to reach USD 789.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 511.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.40% 2032 Value Projection: USD 789.2 Mn

The global veterinary anesthesia drugs market has witnessed significant growth in recent years, driven by the increasing demand for advanced veterinary care and the rising prevalence of chronic diseases among companion animals. Veterinary anesthesia drugs play a crucial role in various surgical procedures, ensuring the safety and comfort of animals during medical interventions. These drugs are used to induce and maintain anesthesia, providing pain relief and muscle relaxation, enabling veterinarians to perform complex surgeries and diagnostic procedures. The market encompasses a wide range of anesthetic agents, including injectable anesthetics, inhalation anesthetics, and local anesthetics, each with unique properties and applications. As pet ownership continues to rise globally and pet owners become more willing to invest in advanced healthcare for their furry companions, the demand for veterinary anesthesia drugs is expected to grow further in the coming years.

Market Dynamics

The global veterinary anesthesia drugs market is influenced by several key factors that drive its growth, pose challenges, and present opportunities. One of the primary drivers is the increasing demand for advanced veterinary care, fueled by the growing pet population and the willingness of pet owners to invest in high-quality medical treatments for their animals. Moreover, the rising prevalence of chronic diseases among companion animals, such as cancer, cardiovascular disorders, and orthopedic conditions, has led to a higher number of surgical procedures, further boosting the demand for veterinary anesthesia drugs. However, the market also faces certain restraints, including the high cost of anesthetic drugs and equipment, which can limit their adoption in cost-sensitive regions. Additionally, the lack of standardized protocols for veterinary anesthesia and the potential side effects associated with certain anesthetic agents may pose challenges to market growth. Despite these restraints, the market presents significant opportunities for manufacturers and suppliers. The development of innovative and safer anesthetic drugs, along with the increasing focus on minimally invasive surgical techniques, is expected to drive market expansion. Furthermore, the growing demand for veterinary anesthesia drugs in emerging economies, coupled with the expanding network of veterinary clinics and hospitals, offers lucrative growth prospects for market players.

Key Features of the Study

  • This report provides in-depth analysis of the global veterinary anesthesia drugs market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global veterinary anesthesia drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Zoetis, Merck Animal Health, Elanco, Bayer Animal Health, Vetoquinol, Dechra Pharmaceuticals, Cegelec, Jorgensen Laboratories, Abaxis, VetMedin, Henry Schein Animal Health, MWI Animal Health, IDEXX Laboratories, Neogen Corporation, and Virbac
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global veterinary anesthesia drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary anesthesia drugs market

Market Segmentation

  • Anesthetic Drug Class Insights (Revenue, USD Mn, 2020 - 2032)
    • General Anesthetics
    • Barbiturates
    • Dissociative Agents (e.g., Ketamine)
    • Inhalant Agents (e.g., Isoflurane, Sevoflurane)
    • Local Anesthetics
    • Lidocaine
    • Bupivacaine
    • Adjunctive Agents
    • Sedatives (e.g., Dexmedetomidine, Medetomidine)
    • Analgesics (e.g., Opioids, NSAIDs)
    • Neuromuscular Blockers etc.
  • Animal Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Companion Animals
    • Livestock Animals
  • Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
    • Intravenous
    • Intramuscular
    • Inhalation
    • Topical
    • Others (Oral-pre-surgical sedation)
  • Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Surgical Procedures
    • Diagnostic Procedures
    • Pain Management
  • Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
    • Veterinary Drug Stores
    • Online Pharmacies
    • Retail Pharmacies
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Hospitals/Clinics
    • Academic & Research Institutes
    • Mobile Veterinary Units
    • others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Zoetis
    • Merck Animal Health
    • Elanco
    • Bayer Animal Health
    • Vetoquinol
    • Dechra Pharmaceuticals
    • Cegelec
    • Jorgensen Laboratories
    • Abaxis
    • VetMedin
    • Henry Schein Animal Health
    • MWI Animal Health
    • IDEXX Laboratories
    • Neogen Corporation
    • Virbac

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Veterinary Anesthesia Drugs Market, By Anesthetic Drug Class
    • Global Veterinary Anesthesia Drugs Market, By Animal Type
    • Global Veterinary Anesthesia Drugs Market, By Route of Administration
    • Global Veterinary Anesthesia Drugs Market, By Application
    • Global Veterinary Anesthesia Drugs Market, By Distribution Channel
    • Global Veterinary Anesthesia Drugs Market, By End User
    • Global Veterinary Anesthesia Drugs Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Veterinary Anesthesia Drugs Market, By Anesthetic Drug Class, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • General Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Barbiturates
  • Dissociative Agents (e.g., Ketamine)
  • Inhalant Agents (e.g., Isoflurane, Sevoflurane)
  • Local Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Lidocaine
  • Bupivacaine
  • Adjunctive Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Sedatives (e.g., Dexmedetomidine, Medetomidine)
  • Analgesics (e.g., Opioids, NSAIDs)
  • Neuromuscular Blockers

5. Global Veterinary Anesthesia Drugs Market, By Animal Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Companion Animals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Livestock Animals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Veterinary Anesthesia Drugs Market, By Route of Administration, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Inhalation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others(Oral-pre-surgical sedation)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Veterinary Anesthesia Drugs Market, By Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Surgical Procedures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Diagnostic Procedures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Veterinary Anesthesia Drugs Market, By Distribution Channel, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Veterinary Drug Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Veterinary Anesthesia Drugs Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals/Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Mobile Veterinary Units
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global Veterinary Anesthesia Drugs Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Zoetis
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elanco
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vetoquinol
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cegelec
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jorgensen Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abaxis
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • VetMedin
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Henry Schein Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MWI Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • IDEXX Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neogen Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Virbac
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제